Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 110,641 | 319,832 | 56,857 | 67,209 |
| Marketable Securities | 232,551 | 31,024 | N/A | N/A |
| TOTAL | $351,171 | $355,923 | $59,804 | $68,444 |
| Non-Current Assets | ||||
| PPE Net | 34 | 185 | 193 | 253 |
| Investments And Advances | 17,272 | 0 | 0 | 0 |
| Other Non-Current Assets | 15,163 | 13,860 | 8,183 | 5,882 |
| TOTAL | $32,469 | $14,045 | $8,376 | $6,135 |
| Total Assets | $383,640 | $369,968 | $68,180 | $74,579 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 7,111 | 17,136 | 5,396 | 5,815 |
| Accrued Expenses | 54,423 | 39,371 | 17,306 | 19,437 |
| TOTAL | $62,649 | $57,292 | $23,258 | $25,967 |
| Non-Current Liabilities | ||||
| Long Term Debt | 78,636 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 211 | 218 | 270,643 | 240,898 |
| TOTAL | $78,847 | $218 | $270,643 | $240,898 |
| Total Liabilities | $141,496 | $57,510 | $293,901 | $266,865 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 57,361 | 41,799 | N/A | N/A |
| Common Shares | 5 | 4 | N/A | N/A |
| Retained earnings | -765,128 | -387,391 | -230,403 | -193,279 |
| Other shareholders' equity | -64 | 194 | 37 | -41 |
| TOTAL | $242,144 | $312,458 | $-225,721 | $-192,286 |
| Total Liabilities And Equity | $383,640 | $369,968 | $68,180 | $74,579 |